🕵️ Vivos Therapeutics, Inc. ($VVOS)
SEC insider & ownership activity, last 12 months · CIK 1716166 · every row links its SEC filing
Over the last 12 months insiders bought $10.4M with no open-market selling against it. Michael C. Skaff bought $10.4M (Mar–Jun). 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jun 8, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $10.4M (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Michael C. Skaff | 8 | $10.4M | 0 | – | Jun 30, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| SP Manager LLC | 19.9% | 13D | Jun 30, 2026 | filing ↗ | |
| Michael C. Skaff | 19.9% | 13D | Jun 30, 2026 | filing ↗ | |
| V-CO Investors 3 LLC | 9.7% | 13D | Jun 30, 2026 | filing ↗ | |
| Dawei Luo | 8.5% | 13G | Jul 14, 2025 | filing ↗ | |
| Armistice Capital, LLC | 8.3% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 8.3% | 13G | May 15, 2026 | filing ↗ | |
| V-CO Investors 2 LLC | 5.9% | 13D | Jun 30, 2026 | filing ↗ | |
| V-CO Investors LLC | exited | 13D | Jun 30, 2026 | filing ↗ | |
| V-CO Investors 4 LLC | exited | 13D | Jun 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 7, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 8, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 8, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 22, 2026 | filing ↗ |
| Earnings (2.02) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 6, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 20, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 16, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 16, 2026 | filing ↗ |